Loading…
Reported covered position: Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Policy issues including supply chain, intellectual property, export and import controls, and international trade, including the BIOSECURE Act (H.R. 7085)
Policy issues including supply chain, intellectual property, export and import controls, and international trade, including the BIOSECURE Act (H.R. 7085)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VICTIMS OF STATE SPONSORED TERRORISM via CROWELL & MORING LLP
2025 · second_quarter · Q2
Funding for U.S. Victims of State Sponsored Terrorism (USVSST) Fund
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
NOVAVAX, INC. via CROWELL & MORING LLP
2025 · second_quarter · Q2
Source: Senate LDA
Policy issues including supply chain, intellectual property, export and import controls, and international trade, including the BIOSECURE Act (H.R. 7085)
Issues related to vaccine policy; Issues related to FDA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via CROWELL & MORING LLP
2025 · second_quarter · Q2
Issues related to appropriations including healthcare and higher education in: FY 2026 appropriations bills, NASA reauthorization, HHS appropriations, Agriculture appropriations, National Institutes of Health appropriations
Issues related to National Institutes of Health grant facilities and administrative cost recovery provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LONZA GROUP AG via CROWELL & MORING LLP
2025 · second_quarter · 2T
Policy issues including supply chain, intellectual property, international trade, and tariffs.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
CARDINAL HEALTH, INC. via CROWELL & MORING LLP
2025 · first_quarter · Q1
Issues related to pharmaceutical drugs and medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
LONZA GROUP AG via CROWELL & MORING LLP
2025 · first_quarter · Q1
Policy issues including supply chain, intellectual property, export and import controls, and international trade, including the BIOSECURE Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
BAYLOR COLLEGE OF MEDICINE via CROWELL & MORING LLP
2025 · first_quarter · Q1
Issues related to appropriations including healthcare and higher education in: FY 2025 appropriations bills, NASA reauthorization, HHS appropriations, Agriculture appropriations, National Institutes of Health appropriations
Issues related to USAID funding; Issues related to President's Emergency Plan for AIDS Relief (PEPFAR) funding; Issues related to Foreign Aid freeze
Issues related to National Institutes of Health grant facilities and administrative cost recovery provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH, INC. via CROWELL & MORING LLP
2024 · fourth_quarter · Q4
Issues related to pharmaceutical drugs and medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LONZA GROUP AG via CROWELL & MORING LLP
2024 · fourth_quarter · Q4
Policy issues including supply chain, intellectual property, export and import controls, and international trade, including the BIOSECURE Act (H.R. 7085)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via CROWELL & MORING LLP
2024 · fourth_quarter · Q4
Issues related to appropriations including healthcare and higher education in: FY 2025 appropriations bills, NASA reauthorization, HHS appropriations, Agriculture appropriations, National Institutes of Health appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LONZA GROUP AG via CROWELL & MORING LLP
2024 · third_quarter · Q3
Policy issues including supply chain, intellectual property, export and import controls, and international trade, including the BIOSECURE Act (H.R. 7085)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVAVAX, INC. via CROWELL & MORING LLP
2024 · third_quarter · Q3
Vaccine policy Pandemic and All-Hazards Preparedness Act reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH, INC. via CROWELL & MORING LLP
2024 · third_quarter · Q3
Issues related to COVID-19, pharmaceutical drugs and medical device supply and logistics Stop Drug Shortages Act discussion draft
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via CROWELL & MORING LLP
2024 · third_quarter · Q3
Issues related to appropriations including healthcare and higher education in: FY 2025 appropriations bills, NASA reauthorization, HHS appropriations, Agriculture appropriations, National Institutes of Health appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LONZA GROUP AG via CROWELL & MORING LLP
2024 · second_quarter · Q2
Policy issues including supply chain, intellectual property, export and import controls, and international trade, including the BIOSECURE Act (H.R. 7085)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYLOR COLLEGE OF MEDICINE via CROWELL & MORING LLP
2024 · second_quarter · Q2
Issues related to appropriations including healthcare and higher education in: FY 2025 appropriations bills, NASA reauthorization, HHS appropriations, Agriculture appropriations, National Institutes of Health appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LONZA GROUP AG via CROWELL & MORING LLP
2024 · second_quarter · RR
Policy issues including supply chain, intellectual property, export and import controls, and international trade.
Policy issues including supply chain, intellectual property, export and import controls, and international trade.